Delaware’s SB 21 Ruling Locks In a New Era of Process-Driven M&A Litigation

Delaware’s SB 21 Ruling Locks In a New Era of Process-Driven M&A Litigation

The Delaware Supreme Court’s decision upholding Senate Bill 21 is not just another chapter in the long-running tug-of-war over stockholder litigation. It is a structural rewrite of how Delaware corporate law allocates power among boards, controllers, and public investors in M&A.

By sustaining the 2025 amendments to the Delaware General Corporation Law, the Court has effectively codified a litigation shutdown rule for many conflicted transactions: if a deal is approved either by a board committee with a majority of independent directors or by a vote of public stockholders, most fiduciary challenges are off the table. That is a dramatic expansion beyond the common-law frameworks lawyers have relied on for years.

Why this matters now

For deal lawyers, the practical consequence is immediate: process is no longer merely evidence of fairness; in many transactions, it is the whole game. Under the traditional Corwin and MFW doctrines, cleansing devices could shift the standard of review or help defendants win dismissal. SB 21 goes further by making compliance with the statutory safe harbors a near-dispositive bar to suit.

That means transaction planning in controller deals, squeeze-outs, and conflicted board approvals will increasingly begin with one question: can the deal be structured to fit the statute? If the answer is yes, Delaware has sharply reduced the utility of post-signing fiduciary litigation as a price-adjustment tool.

The end of 220 as a reliable pre-suit weapon?

Just as important is what SB 21 does to books-and-records practice. Section 220 has long functioned as the plaintiffs’ bar’s best discovery substitute: a way to test independence, conflicts, and process before filing. The new statute’s restrictions on inspection rights make that path narrower and less predictable.

That shift matters because Delaware litigation has always been information-sensitive. If stockholders cannot easily obtain the materials needed to plead around a cleansing structure, the statute’s substantive protections become even more powerful in practice than they appear on paper.

Federal disclosure becomes the real battleground

The likely consequence is not less litigation overall, but different litigation. As state fiduciary claims narrow, fights will migrate toward federal securities theories centered on proxy disclosure, omissions, and materially misleading statements. In other words, Delaware is pushing disputes into the Rule 14a-9 ecosystem.

That raises the stakes for proxy drafting. If state-law review is limited once the statutory boxes are checked, the quality of disclosure about conflicts, committee composition, independence, and negotiation history becomes the principal remaining pressure point. Expect plaintiffs to argue that cleansing was ineffective because the vote was uninformed, not because the process itself failed Delaware fiduciary law.

Boards should not mistake this for a free pass

There is a temptation to read SB 21 as a blanket immunity statute. That would be a mistake. The safe harbors still depend on real process: a genuinely independent committee, meaningful deliberation, and a stockholder vote that is not structurally defective or disclosure-impaired. Sloppy process can still create litigation risk, just under different theories and in different forums.

Nor does the ruling eliminate every species of Delaware challenge. Waste, bad faith in extreme cases, defective approvals, and noncompliance with the statute itself will remain live issues. But the center of gravity has shifted unmistakably toward ex ante process design and away from ex post fiduciary second-guessing.

The bigger picture

Delaware has now sent a very clear signal: it intends to preserve its franchise as the dominant state of incorporation by reducing the friction and cost of stockholder deal litigation. Critics will say the Court has weakened accountability for controllers and conflicted boards. Supporters will say Delaware has finally aligned doctrine with the reality that most merger suits were settlement leverage, not substantive wrongdoing.

Both readings contain some truth. What is undeniable is that SB 21 changes bargaining leverage in public-company M&A. Plaintiffs lose a familiar weapon. Boards gain a more reliable roadmap to closing. And disclosure lawyers inherit a larger role in policing the fairness story that Delaware courts will now be less willing to revisit.

Practice takeaway: In 2026, the best M&A defense is no longer a strong fairness narrative after the fact. It is a meticulously engineered approval process before signing, paired with proxy disclosure robust enough to survive federal scrutiny.